CGON insider buying – CG Oncology, Inc.
6 insider purchases since 2016 worth $87.5M by 5 different insiders. Last 12 months: 1 purchases, $24.8M. Most recent filing: 2026-06-29.
Same time range as the chart above - each mark sits under the week of the trade. Circles = purchases (height = price paid, size = amount), red triangles = open-market sales of $50k+. Prices as reported, not adjusted for later stock splits.
Purchases are open-market buys (SEC Form 4, code "P") - insiders paying with their own money. Sales are open-market sales (code "S") of $50,000 or more; many sales are pre-planned (Rule 10b5-1) or made for taxes and diversification. Each row links to the original filing.
Bought, sold, still holding?
| Insider | Bought | First / last buy | Sold since 2016 | Holds now* | Status |
|---|---|---|---|---|---|
| Liu Brian Guan-Chyun Director | $74.8M 2× · 1,886,236 sh | 2025-09-11 2026-06-25 | – | 1,886,236 shares as of 2026-06-29 | Holds - never sold |
| Decheng Capital Global Healthcare Fund (Master), LP 10% Owner | $7.6M 1× · 400,000 sh | 2024-01-29 2024-01-29 | – | 4,958,812 shares as of 2024-01-31 | Holds - never sold |
| Song Hong Fang Director | $5.0M 1× · 263,157 sh | 2024-01-29 2024-01-29 | 3× · $45.4M last 2025-09-03 | 7,039,077 shares as of 2025-09-04 | Sold part |
| Roche Corleen M. CFO | $38,000 1× · 2,000 sh | 2024-01-29 2024-01-29 | – | 2,000 shares as of 2024-01-31 | Holds - never sold |
| Kasturi Vijay Officer | $24,985 1× · 1,315 sh | 2024-01-29 2024-01-29 | – | 1,315 shares as of 2024-01-31 | Holds - never sold |
* Shares held after the insider's most recent SEC filing for this company (all share classes, direct and indirect). If an insider stops filing, later changes are not known.
Insider buying and selling by year
| Year | Purchases | Bought | Buyers | Sales | Sold |
|---|---|---|---|---|---|
| 2026 | 1 | $24.8M | 1 | 11 | $4.7M |
| 2025 | 1 | $50.0M | 1 | 7 | $5.5M |
| 2024 | 4 | $12.7M | 4 | 2 | $42.6M |
Insider purchases
| Filed | Insider | Role | Shares | Avg price | Value | Holdings | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-29 | Liu Brian Guan-Chyun | Director | 371,085 | $66.87 | $24.8M | +24.5% | SEC |
| 2025-09-15 | Liu Brian Guan-Chyun | Director | 1,515,151 | $33.00 | $50.0M | SEC | |
| 2024-01-31 | Song Hong Fang | Director | 263,157 | $19.00 | $5.0M | +75.0% | SEC |
| 2024-01-31 | Roche Corleen M. | CFO | 2,000 | $19.00 | $38,000 | SEC | |
| 2024-01-31 | Kasturi Vijay | Officer | 1,315 | $19.00 | $24,985 | SEC | |
| 2024-01-31 | Decheng Capital Global Healthcare Fund (Master), LP | 10% Owner | 400,000 | $19.00 | $7.6M | SEC |
Insider sales
| Filed | Insider | Role | Shares | Avg price | Value | Type | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-17 | POST LEONARD E | Director | 1,000 | $72.98 | $72,980 | Sale | SEC |
| 2026-08-18 | POST LEONARD E | Director | 1,000 | $74.54 | $74,540 | Sale | SEC |
| 2026-07-17 | POST LEONARD E | Director | 1,000 | $71.17 | $71,170 | Sale | SEC |
| 2026-07-14 | Mulay James | Director | 24,165 | $75.16 | $1.8M | Sale | SEC |
| 2026-06-25 | POST LEONARD E | Director | 5,000 | $70.00 | $350,000 | Sale | SEC |
| 2026-06-23 | POST LEONARD E | Director | 5,000 | $65.00 | $325,000 | Sale | SEC |
| 2026-06-16 | Mulay James | Director | 1,964 | $60.12 | $118,076 | Pre-planned (10b5-1) | SEC |
| 2026-06-05 | POST LEONARD E | Director | 1,000 | $54.50 | $54,500 | Sale | SEC |
| 2026-04-20 | Mulay James | Director | 15,600 | $73.01 | $1.1M | Sale | SEC |
| 2026-03-17 | Mulay James | Director | 1,964 | $63.50 | $124,714 | Sale | SEC |
| 2026-01-13 | Mulay James | Director | 11,145 | $52.47 | $584,799 | Sale | SEC |
| 2025-10-10 | Mulay James | Director | 5,903 | $43.99 | $259,673 | Sale | SEC |
| 2025-10-01 | POST LEONARD E | Director | 5,000 | $40.09 | $200,450 | Sale | SEC |
| 2025-09-30 | Mulay James | Director | 12,755 | $39.19 | $499,868 | Sale | SEC |
| 2025-09-22 | Mulay James | Director | 22,686 | $39.01 | $884,909 | Sale | SEC |
Showing the latest 15 of 20 sales of $50,000+ since 2016.
Compiled automatically from public SEC filings. Not investment advice. Get every new insider purchase in the daily report.
Get every new insider purchase the day it's filed
Daily report with all SEC insider buys, cluster buys, company events and the crypto money-flow radar.
Get started free